Drug intelligence / Profile preview

OR-AT0222

Development stage
Preclinical
Lead developer
Devintec
Administration
Topical
01

Overview

OR-AT0222 is a topical oral gel developed by Devintec Sagl for the management of recurrent aphthous ulcers (canker sores), aphthous stomatitis, and minor oral lesions. The product functions by forming a persistent protective film over the affected area, creating a physical barrier that protects the lesion from external irritants such as food, drink, and bacteria. This barrier effect is intended to facilitate wound healing, provide symptomatic pain relief, and reduce the risk of further irritation. It is currently undergoing clinical investigation to evaluate its efficacy and safety in patients with oral ulcers.

Beyond the preview

Go deeper on OR-AT0222.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OR-AT0222.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call